MOTS-c guidebook
Choose a chapter

A care guide in everyday words

MOTS-c treatment. Start with the facts.

Understand the evidence. Compare care routes. Bring clear questions to a visit.

At the September 30, 2026 check, MOTS-c had no approval in the United States from the Food and Drug Administration (FDA).

The US agency responsible for medicine reviews is FDA.

An empty linen chair beside a tall window, with soft light crossing a stone floor.

A real substance. An open treatment question.

Your body makes MOTS-c, a peptide whose small chain uses the same building blocks as proteins.

  • By September 30, 2026, no published study had shown what giving MOTS-c itself to people does.
  • At that same September 30, 2026 check, its safety in people was still unknown.
  • Begin by naming the health problem you want help with, before naming a product.
Open the source drawer

Compare the conversation before the offer.

The useful first choice is how to get your health goal assessed. Each route gives you different questions to ask.

In a room

An in-person visit puts you and a health professional, called a clinician, in the same place.

  • Ask what the visit will assess.
  • Ask how any tests and later visits are arranged.

Over a screen

Care delivered through video, phone, or written messages is called telehealth; you and the clinician are apart.

  • Ask who will review your history.
  • Ask how you can raise a new question after the visit.

Through research

A trial record describes a study plan. Read it to see what the study will test and who may take part.

  • Look for posted results, not just a study title.
  • Check whether the study gives MOTS-c or only measures what the body makes.
  • Ask the study team whether you can take part.
Compare these care routes

Go to the answer you need.

Choose a chapter that fits the question on your mind.